AIRLINK 69.40 Decreased By ▼ -3.66 (-5.01%)
BOP 4.90 Decreased By ▼ -0.19 (-3.73%)
CNERGY 4.24 Decreased By ▼ -0.13 (-2.97%)
DFML 31.66 Decreased By ▼ -0.79 (-2.43%)
DGKC 76.82 Increased By ▲ 1.33 (1.76%)
FCCL 19.97 Increased By ▲ 0.45 (2.31%)
FFBL 34.93 Decreased By ▼ -1.22 (-3.37%)
FFL 9.12 Decreased By ▼ -0.10 (-1.08%)
GGL 9.80 Decreased By ▼ -0.05 (-0.51%)
HBL 112.66 Decreased By ▼ -4.04 (-3.46%)
HUBC 132.80 Increased By ▲ 0.11 (0.08%)
HUMNL 6.95 Decreased By ▼ -0.15 (-2.11%)
KEL 4.19 Decreased By ▼ -0.22 (-4.99%)
KOSM 4.25 Decreased By ▼ -0.15 (-3.41%)
MLCF 36.45 Increased By ▲ 0.25 (0.69%)
OGDC 132.94 Decreased By ▼ -0.56 (-0.42%)
PAEL 22.50 Decreased By ▼ -0.10 (-0.44%)
PIAA 24.20 Decreased By ▼ -1.81 (-6.96%)
PIBTL 6.46 Decreased By ▼ -0.09 (-1.37%)
PPL 116.40 Increased By ▲ 1.09 (0.95%)
PRL 25.88 Decreased By ▼ -0.75 (-2.82%)
PTC 13.03 Decreased By ▼ -1.07 (-7.59%)
SEARL 51.95 Decreased By ▼ -1.50 (-2.81%)
SNGP 67.50 Increased By ▲ 0.25 (0.37%)
SSGC 10.54 Decreased By ▼ -0.16 (-1.5%)
TELE 8.23 Decreased By ▼ -0.19 (-2.26%)
TPLP 10.79 Increased By ▲ 0.04 (0.37%)
TRG 59.21 Decreased By ▼ -4.66 (-7.3%)
UNITY 25.14 Increased By ▲ 0.02 (0.08%)
WTL 1.27 No Change ▼ 0.00 (0%)
BR100 7,391 Decreased By -70.2 (-0.94%)
BR30 23,921 Decreased By -250.4 (-1.04%)
KSE100 70,683 Decreased By -419.1 (-0.59%)
KSE30 23,253 Decreased By -142 (-0.61%)
World

UK says Astrazeneca vaccine prevents COVID-19 death as South Africa halts shots

  • "There is no evidence that this vaccine is not effective in preventing hospitalisation and severe illness and death, which ultimately is what we're seeking with these vaccines today," Britain's Edward Argar told Sky.
Published February 8, 2021

LONDON: There is no evidence that the Astrazeneca vaccine does not prevent death or serious illness, and South Africa has only imposed a temporary halt on using the vaccine, a British junior health minister said on Monday.

South Africa will put on hold use of AstraZeneca's COVID-19 shot in its vaccination programme after data showed it gave minimal protection against mild-to-moderate infection caused by the country's dominant coronavirus variant.

"There is no evidence that this vaccine is not effective in preventing hospitalisation and severe illness and death, which ultimately is what we're seeking with these vaccines today," Britain's Edward Argar told Sky.

"The dominant strains in this country are not the South African strain, there are a small number of cases of that, the dominant strains here are the historic one we've had, and then the Kent variant, against which this vaccine is highly effective."

Comments

Comments are closed.